StockData
Zenas BioPharma, Inc. logo

Zenas BioPharma, Inc. (ZBIO) stock

ZBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$27.93−0.08 (-0.29%)

Close on Nov 16, 2026Market cap $1.82BP/E –Yield –

What it earns on the capital it uses

Trailing twelve months over average capital

Return on equity-265.1%vs -53.5%
Return on assets-108.7%vs -40.7%
Return on capital employed-86.1%vs -38.7%

How hard the assets work

Profit per employee-$3.24Mvs -$704.12K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by $423.86M. That is 30.4% of the $1.40B it would cost to buy the business outright.

Total debt$223.24M
Cash and short-term investments$647.10M
EBITDA, trailing twelve months-$526.40M
Free cash flow, trailing twelve months-$242.83M

Leverage and liquidity

Debt to equity1.05vs 0.50
Current ratio9.42vs 3.30
Quick ratio10.10vs 2.39

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

-1.47
DistressGrey zoneSafe

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

1 of 9 tests passed

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Earnings yield-29.8%vs -22.5%
Free cash flow yield-13.3%vs -9.27%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 16, 2026

$13.5052-week low52-week high$44.60
200-day$27.9320-day50-day

The close sits 46% of the way up the 52-week range, 37.4% below the high.

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

50
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

ZBIOS&P 500
PeriodZBIOS&P 500DifferenceZBIO per yearS&P 500 per year
1 month+12.4%-3.1%+15.5 pts
3 months-5.4%-4.5%−0.9 pts
Year to date-23.1%+9.4%−32.4 pts
1 year-20.2%+11.3%−31.5 pts

How much it moves

Volatility, 1 year95.1%vs 80.4%
Volume against its 90-day average0.94vs 0.86

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

11M ZBIO shares were sold short on Oct 30, 2026, down 9.4% from the previous report, or 27.27% of the shares available to trade. At recent volumes it would take 24.1 days to buy them back. Over the last 20 sessions, 63.9% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Short interest as a share of the float27.3%vs 8.91%
Short interest as a share of all shares17.4%vs 6.30%
Days of volume to buy it back24.08vs 5.16

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202611,354,403-9.4%471,47524.1
Oct 15, 202612,538,549+5.0%666,05818.8
Sep 30, 202611,941,601+0.6%771,65315.5
Sep 15, 202611,871,346+1.4%529,25122.4
Aug 31, 202611,702,288+0.4%825,02314.2
Aug 14, 202611,658,986-0.8%553,67021.1
Jul 31, 202611,753,566-3.4%850,07613.8
Jul 15, 202612,169,907-0.2%976,88012.5
Jun 30, 202612,196,436+9.6%1,264,7179.6
Jun 15, 202611,131,739+2.3%575,80219.3
May 29, 202610,879,470+1.8%599,92218.1
May 15, 202610,687,286-1.5%501,40521.3

Every measure, in full

61 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 15, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 16, 2026

Valuation ratiosIndustry

Market Cap
$1.82B
$261.21M
Enterprise Value
$1.40B
$135.05M
PB Ratio
8.57
2.00
P/TBV Ratio
8.57
2.22

Share statisticsIndustry

Shares Change (QoQ)
7.05%
0.57%
Float
42M
49M
Shares Held by Insiders
36.1%
11.2%
Shares Held by Institutions
94.0%
56.2%

Short sellingIndustry

Short Interest
11M
–
Short Interest Change
-9.44%
-0.81%
Short % of Float
27.3%
8.91%
Short % of Shares Outstanding
17.4%
6.30%
Days to Cover
24.08
5.16

Stock price statisticsIndustry

52-Week High
$44.60
–
52-Week Low
$13.50
–
20-Day Moving Average
$28.00
–
50-Day Moving Average
$28.48
–
200-Day Moving Average
$25.39
–
Average True Range (14)
$1.71
–
Price Change (1 Week)
-2.24%
-7.55%
Price Change (1 Month)
12.4%
-4.88%
Price Change (3 Months)
-12.5%
-24.2%
Price Change (6 Months)
65.2%
-21.7%
Price Change (YTD)
-23.1%
-26.2%
Price Change (1 Year)
-21.7%
-22.5%
Average Volume (10 Days)
567,627
–
Average Volume (20 Days)
498,958
–
Average Volume (90 Days)
664,019
–
Relative Volume
0.94
0.86
Relative Strength Index (14)
49.7
40.8
Volatility (1 Year)
95.1%
80.4%

Returns on capitalIndustry

Return on Equity (ROE)
-265.1%
-53.5%
Return on Assets (ROA)
-108.7%
-40.7%
Return on Capital Employed (ROCE)
-86.1%
-38.7%

Financial positionIndustry

Current Ratio
9.42
3.30
Quick Ratio
10.10
2.39
Debt / Equity
1.05
0.50

EfficiencyIndustry

Profits Per Employee
-$3.24M
-$704.12K
Employee Count
167
75

Income statement (TTM)Industry

Operating Income
-$526.40M
-$21.49M
Pretax Income
-$541.54M
-$14.83M
Net Income
-$541.81M
-$22.47M
EBITDA
-$526.40M
-$17.14M
EPS (Diluted)
-$9.41
-$0.83

Balance sheetIndustry

Total Debt
$223.24M
$116.91M
Net Cash (Debt)
$423.86M
$15.35M
Net Cash Per Share
$6.50
$0.71
Equity (Book Value)
$212.31M
$49.84M
Book Value Per Share
$3.26
$1.45
Tangible Book Value
$212.31M
$23.91M
Working Capital
$539.41M
$74.41M

Cash flow (TTM)Industry

Operating Cash Flow
-$242.83M
-$12.17M
Capital Expenditures
-$3.00K
-$1.03M
Free Cash Flow
-$242.83M
-$20.28M
FCF Per Share
-$3.73
-$0.42

Dividends and yieldsIndustry

Earnings Yield
-29.8%
-22.5%
FCF Yield
-13.3%
-9.27%

Scores and fair valueIndustry

Altman Z-Score
-1.47
0.22
Piotroski F-Score
1
4

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?